Good self-management helps to reduce diabetic mortality

March 26, 2014

People with type 2 diabetes who report good self-management behavior have a reduced mortality risk. This was the result of a population-based study conducted by scientists at Helmholtz Zentrum München emphasizing the great importance of patient behavior in the diabetes treatment process. These findings were published in the journal Diabetes Care.

Scientists of the Institute of Health Economics and Health Care Management (IGM) and of the Institute of Epidemiology II (EPI II) at Helmholtz Zentrum München (HMGU), together with colleagues of the German Diabetes Center (DDZ) in Düsseldorf, investigated the association between self-management behavior and mortality in patients with . HMGU and the DDZ are partners in the German Center for Diabetes Research (DZD).

High self-management index – low mortality

340 study participants with type 2 were interviewed with regard to their patient behavior – e.g. regular monitoring of blood glucose levels, having a diet plan or performing physical exercise. Based on this data a self-management index was defined. The team led by Professor Rolf Holle and Michael Laxy correlated the index with the mortality of the participants, who were monitored over a period of 12 years. The analysis showed that patients with good diabetes self-management, that is patients with a high self-management index, had a significantly lower than with a low self-management index. This association exists independent of other factors that can influence , such as age, sex, comorbidities or medication.

Active participation of the patient in the treatment is important

"The results show that in addition to physician delivered according to medical guidelines, the patient's behavior is also of great significance for the course of the disease and for the success of the treatment process ", said Holle, group leader of the research group Economic Evaluation at the IGM. "Patient-centered services, such as diabetes education, self-management training and information services therefore make a valuable contribution to good patient care and should continue to be expanded."

The basis of the analyzed data is the KORA*-A study, which is composed of participants of two previous population-based health surveys and of the KORA Myocardial Infarction Registry from the Augsburg area.

Diabetes affects nearly ten percent of the population in Germany. The aim of Helmholtz Zentrum München is to develop new approaches to diagnosis, treatment and prevention of common diseases.

Explore further: Posttraumatic stress disorder associated with type 2 diabetes

More information: Laxy, M. et al. (2014), "The Association Between Patient-Reported Self-Management Behavior, Intermediate Clinical Outcomes, and Mortality in Patients With Type 2 Diabetes: Results From the KORA-A Study," Diabetes Care, DOI: 10.2337/dc13-2533

Related Stories

Type 1 diabetes: Vitamin D deficiency occurs in an early stage

February 27, 2014

Vitamin D is known as a major regulator of calcium levels and bone metabolism. Furthermore, it also influences the immune system. Previous studies have shown that patients with recently diagnosed type 1 diabetes have significantly ...

Antibody affinity is decisive in Type 1 diabetes in adults

March 11, 2014

Patients with LADA – a form of autoimmune type 1 diabetes in adulthood – can be distinguished from patients with non-autoimmune type 2 diabetes by means of the antibody reaction affinity to the enzyme glutamic acid decarboxylase ...

Recommended for you

Diets avoiding dry-cooked foods can protect against diabetes

August 24, 2016

Simple changes in how we cook could go a long way towards preventing diabetes, say researchers at the Icahn School of Medicine at Mount Sinai. A new randomized controlled trial, published online July 29 in the journal Diabetologia, ...

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Gene variant explains differences in diabetes drug response

August 9, 2016

The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.